| Not Yet Recruiting | Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colore Advanced Microsatellite Stable Colorectal Cancer | Phase 2 | 2026-04-01 |
| Recruiting | Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention HIV Infections | — | 2026-03-17 |
| Withdrawn | Study of Obeldesivir as Postexposure Prophylaxis for Filovirus Diseases Virus Disease Filovirus Disease, Postexposure Prophylaxis for Filovirus Disease | Phase 2 | 2025-12-01 |
| Recruiting | Study of GS-5319 in Adults With Solid Tumors Advanced Solid Tumor | Phase 1 | 2025-08-28 |
| Active Not Recruiting | Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV HIV-1-infection | Phase 1 | 2025-08-12 |
| Terminated | Study of GS-1219 in Participants With HIV-1 HIV-1-infection | Phase 1 | 2025-08-11 |
| Recruiting | Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus Chronic Hepatitis Delta | Phase 1 / Phase 2 | 2025-07-31 |
| Recruiting | Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) HIV Pre-exposure Prophylaxis | Phase 3 | 2025-07-22 |
| Recruiting | Study of GS-3242 in Participants With HIV-1; Substudy-05 HIV-1-infection | Phase 1 | 2025-05-29 |
| Recruiting | Study of GS-0151 in Participants With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2025-05-14 |
| Recruiting | A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Tripl Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2025-04-30 |
| Recruiting | Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 3 | 2025-04-04 |
| Recruiting | Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Chil HIV-1-infection | Phase 2 | 2025-03-26 |
| Terminated | Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection RSV Infection | Phase 2 | 2025-03-05 |
| Completed | A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain Breast Cancer | — | 2025-02-21 |
| Active Not Recruiting | Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Rega Head and Neck Squamous Cell Carcinoma | Phase 2 | 2025-02-18 |
| Recruiting | Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 HIV-1-infection | Phase 2 / Phase 3 | 2024-11-20 |
| Terminated | Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated HIV-1-infection | Phase 2 / Phase 3 | 2024-10-21 |
| Terminated | Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection RSV Infection | Phase 2 | 2024-10-14 |
| Active Not Recruiting | Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafen HIV-1-infection | Phase 3 | 2024-10-09 |
| Active Not Recruiting | Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppress HIV-1-Infection | Phase 3 | 2024-10-08 |
| Active Not Recruiting | Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) Pre-Exposure Prophylaxis of HIV Infection | Phase 2 | 2024-10-07 |
| Recruiting | Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type Weight Management | Phase 1 | 2024-08-28 |
| Active Not Recruiting | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Endometrial Cancer | Phase 3 | 2024-08-28 |
| Recruiting | A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Stud HIV-1-infection | Phase 4 | 2024-08-27 |
| Active Not Recruiting | Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Bikt HIV-1-Infection | Phase 2 / Phase 3 | 2024-08-20 |
| Recruiting | Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-07-26 |
| Active Not Recruiting | Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2024-03-27 |
| Active Not Recruiting | Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Trea HIV-1-infection | Phase 3 | 2024-03-25 |
| Recruiting | Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-01-09 |
| Terminated | Study of Obeldesivir in Children and Adolescents With COVID-19 COVID-19 | Phase 2 / Phase 3 | 2023-12-26 |
| Active Not Recruiting | Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People W Pre-Exposure Prophylaxis of HIV Infection | Phase 2 | 2023-12-13 |
| Completed | Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER) HIV-1-infection | Phase 4 | 2023-12-13 |
| Recruiting | Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2023-12-05 |
| Active Not Recruiting | Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Pre-Exposure Prophylaxis of HIV Infection | Phase 2 | 2023-11-17 |
| Active Not Recruiting | Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors Solid Tumors | Phase 1 | 2023-10-09 |
| Active Not Recruiting | Study of GS-0272 in Participants With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2023-09-28 |
| Recruiting | Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis Primary Biliary Cholangitis | Phase 3 | 2023-09-07 |
| Active Not Recruiting | Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects Wi Primary Biliary Cholangitis | Phase 3 | 2023-09-05 |
| Active Not Recruiting | A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppr HIV Infection | Phase 2 | 2023-05-15 |
| Active Not Recruiting | Study of GS-4528 in Adults With Solid Tumors Solid Tumor | Phase 1 | 2023-05-11 |
| Active Not Recruiting | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positi Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer | Phase 3 | 2023-05-08 |
| Terminated | Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) Cutaneous Lupus Erythematosus (CLE) | Phase 2 | 2023-04-17 |
| Completed | Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic He Chronic Hepatitis B | Phase 1 | 2023-04-03 |
| Recruiting | Study of Novel Treatment Combinations in Patients With Lung Cancer Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer | Phase 2 | 2023-03-16 |
| Completed | Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function Hepatic Impairment, Healthy | Phase 1 | 2023-03-15 |
| Completed | A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function Chronic Hepatitis D Infection | Phase 1 | 2023-03-15 |
| Active Not Recruiting | Study With Various Immunotherapy Treatments in Participants With Lung Cancer Advanced Non-Small Cell Lung Cancer | Phase 2 | 2023-02-21 |
| Completed | Study of Obeldesivir in Nonhospitalized Participants With COVID-19 COVID-19 | Phase 3 | 2023-02-08 |
| Active Not Recruiting | Study of Bulevirtide in Participants With Chronic Hepatitis D Infection Chronic Hepatitis D Infection | — | 2023-02-07 |
| Recruiting | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer | Phase 3 | 2022-12-12 |
| Terminated | Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illnes COVID-19 | Phase 3 | 2022-11-05 |
| Completed | Study of Novel Antiretrovirals in Participants With HIV-1 HIV-1-infection | Phase 1 | 2022-10-26 |
| Active Not Recruiting | Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patie Non-small Cell Lung Cancer | Phase 3 | 2022-10-12 |
| Terminated | Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels Human Immunodeficiency Virus Type 1 (HIV-1) Infection | Phase 1 | 2022-08-19 |
| Active Not Recruiting | Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Trea HIV-1-infection | Phase 2 / Phase 3 | 2022-08-16 |
| Active Not Recruiting | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab Triple Negative Breast Cancer, PD-L1 Positive | Phase 3 | 2022-07-25 |
| Active Not Recruiting | Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreat Triple Negative Breast Cancer, PD-L1 Negative | Phase 3 | 2022-07-20 |
| Terminated | Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Adva Metastatic Colorectal Cancer | Phase 2 | 2022-07-08 |
| Terminated | Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute M Acute Myeloid Leukemia | Phase 3 | 2022-07-07 |
| Withdrawn | Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthrit Rheumatoid Arthritis | Phase 2 | 2022-07-01 |
| Completed | Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Wome HIV-1-infection | Phase 2 | 2022-06-09 |
| Active Not Recruiting | Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastati Non-small Cell Lung Cancer | Phase 2 | 2022-05-30 |
| Terminated | Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastat Triple-Negative Breast Cancer | Phase 2 | 2021-12-14 |
| Active Not Recruiting | Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cel Non-Small Cell Lung Cancer | Phase 3 | 2021-11-17 |
| Terminated | Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2021-11-09 |
| Active Not Recruiting | Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors Advanced Solid Tumor, Metastatic Triple-Negative Breast Cancer, HR+/HER2- Metastatic Breast Cancer | Phase 1 / Phase 2 | 2021-10-20 |
| Active Not Recruiting | Study of Sacituzumab Govitecan in Patients With Solid Tumor Solid Tumor | Phase 2 | 2021-10-12 |
| Active Not Recruiting | Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppre HIV-1 Infection | Phase 2 | 2021-10-05 |
| Terminated | Study of Magrolimab in Patients With Solid Tumors Solid Tumor | Phase 2 | 2021-10-01 |
| Completed | An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Primary Biliary Cholangitis, Compensated Cirrhosis, Hepatic Impairment | Phase 1 | 2021-09-17 |
| Active Not Recruiting | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination Solid Malignancies | Phase 1 | 2021-09-15 |
| Terminated | Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma | Phase 2 | 2021-09-07 |
| Terminated | Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) Cutaneous Lupus Erythematosus | Phase 1 | 2021-09-01 |
| Active Not Recruiting | Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Pre-Exposure Prophylaxis of HIV Infection | Phase 3 | 2021-08-30 |
| Recruiting | Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2021-08-18 |
| Completed | Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Tre Chronic Hepatitis B | Phase 2 | 2021-08-14 |
| Completed | Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Non Nonalcoholic Steatohepatitis | Phase 2 | 2021-08-09 |
| Withdrawn | Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Re Chronic Spontaneous Urticaria | Phase 2 | 2021-07-01 |
| Terminated | Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination Wit Acute Myeloid Leukemia | Phase 3 | 2021-07-01 |
| Active Not Recruiting | Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection Pre-Exposure Prophylaxis of HIV Infection | Phase 3 | 2021-06-28 |
| Terminated | Study of Magrolimab Combinations in Participants With Myeloid Malignancies Myeloid Malignancies | Phase 2 | 2021-06-28 |
| Completed | RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control Primary Biliary Cholangitis | Phase 3 | 2021-04-21 |
| Completed | Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Vi HIV-1 Infection | Phase 1 | 2021-04-08 |
| Recruiting | Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impa Advanced or Metastatic Solid Tumor, Liver Failure | Phase 1 | 2021-04-06 |
| Terminated | Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function COVID-19 | Phase 3 | 2021-03-31 |
| Terminated | Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2021-03-25 |
| Completed | Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer T Locally Advanced or Metastatic Unresectable Urothelial Cancer | Phase 3 | 2021-01-13 |
| Withdrawn | Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Ankylosing Spondylitis | Phase 3 | 2020-12-01 |
| Withdrawn | Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Ankylosing Spondylitis | Phase 3 | 2020-12-01 |
| Active Not Recruiting | Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC) Metastatic Breast Cancer | Phase 3 | 2020-11-23 |
| Terminated | Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Rela Non-hodgkin Lymphoma | Phase 1 | 2020-11-17 |
| Completed | Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Be Rheumatoid Arthritis | Phase 1 | 2020-11-04 |
| Active Not Recruiting | Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received Metastatic Triple-negative Breast Cancer | Phase 2 | 2020-10-23 |
| Terminated | Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVI COVID-19 | Phase 3 | 2020-09-18 |
| Completed | Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, a COVID-19 | Phase 1 / Phase 2 | 2020-09-14 |
| Terminated | Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 3 | 2020-09-09 |
| Completed | Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan Metastatic Solid Tumors | Phase 4 | 2020-08-04 |
| Completed | Study of Remdesivir in Participants Below 18 Years Old With COVID-19 COVID-19 | Phase 2 / Phase 3 | 2020-07-21 |
| Completed | Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406 Healthy Volunteers | Phase 1 | 2020-07-07 |
| Completed | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Cor COVID-19 | Phase 3 | 2020-03-15 |
| Completed | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coron COVID-19 | Phase 3 | 2020-03-06 |
| Completed | Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) Hepatitis C Virus Infection | Phase 3 | 2020-01-03 |
| Terminated | Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerati Ulcerative Colitis | Phase 2 | 2019-12-20 |
| Terminated | Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Ar Psoriatic Arthritis | Phase 3 | 2019-12-03 |
| Completed | Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Ag HIV-1-infection | Phase 2 | 2019-11-22 |
| Active Not Recruiting | Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background HIV-1-infection | Phase 2 / Phase 3 | 2019-11-21 |
| Terminated | Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Ha Psoriatic Arthritis | Phase 3 | 2019-11-13 |
| Terminated | A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC Primary Sclerosing Cholangitis | Phase 2 | 2019-11-12 |
| Terminated | Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Primary Sclerosing Cholangitis, Compensated Cirrhosis | Phase 1 | 2019-10-17 |
| Completed | Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Hepatitis C Virus Infection | Phase 3 | 2019-10-16 |
| Active Not Recruiting | Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors Metastatic Solid Tumor | Phase 2 | 2019-10-15 |
| Terminated | Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Pa Advanced Solid Tumors | Phase 1 | 2019-08-26 |
| Completed | Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic S Nonalcoholic Steatohepatitis | Phase 2 | 2019-07-29 |
| Completed | Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Ki Diabetic Kidney Disease | Phase 2 | 2019-07-24 |
| Completed | Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bicteg HIV-1-infection | — | 2019-07-09 |
| Completed | Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus ( HIV-1-infection | Phase 1 | 2019-06-28 |
| Terminated | Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-06-03 |
| Withdrawn | Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents Diffuse Large B-Cell Lymphoma, Mediastinal B-cell Lymphoma | Phase 1 | 2019-06-01 |
| Completed | Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Partici Chronic Hepatitis Delta | Phase 2 | 2019-05-31 |
| Completed | Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Meta Metastatic Breast Cancer | Phase 3 | 2019-05-08 |
| Terminated | Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ C Human Papillomavirus (HPV) 16+ Relapsed/Refractory Cancer | Phase 1 | 2019-04-30 |
| Completed | Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD) Chronic Hepatitis Delta | Phase 3 | 2019-04-17 |
| Terminated | Study of Cilofexor in Adults With Primary Sclerosing Cholangitis Primary Sclerosing Cholangitis | Phase 3 | 2019-03-27 |
| Terminated | Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX Hepatitis C Virus Infection | Phase 2 | 2019-01-28 |
| Completed | Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously HIV-1 Infection | Phase 1 | 2018-11-26 |
| Completed | Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bicteg HIV-1-infection | — | 2018-11-13 |
| Terminated | Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib B-cell Malignancies | — | 2018-10-23 |
| Completed | ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Int Primary Biliary Cholangitis | Phase 3 | 2018-10-01 |
| Completed | Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib Chronic Lymphocytic Leukaemia | — | 2018-09-12 |
| Completed | Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a HIV-1 Infection | Phase 3 | 2018-08-28 |
| Completed | Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Vire Chronic Hepatitis B | Phase 2 | 2018-08-28 |
| Recruiting | Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread Metastatic Urothelial Cancer | Phase 2 | 2018-08-13 |
| Completed | Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Ten HIV-1/HBV Co-Infection | Phase 3 | 2018-05-30 |
| Completed | Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma Follicular Non-Hodgkin's Lymphoma Refractory | — | 2018-05-25 |
| Completed | Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibit Ovarian Cancer | Phase 1 | 2018-05-23 |
| Terminated | A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH) NASH - Nonalcoholic Steatohepatitis | Phase 2 | 2018-04-30 |
| Completed | Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic H Chronic Hepatitis B | Phase 2 | 2018-04-06 |
| Completed | Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function Rheumatoid Arthritis | Phase 1 | 2018-04-03 |
| Terminated | Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infec HIV-1-infection | Phase 2 | 2018-04-03 |
| Completed | Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Particip Nonalcoholic Steatohepatitis | Phase 2 | 2018-03-21 |
| Completed | Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen HIV-1 Infection | Phase 3 | 2018-03-01 |
| Terminated | Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Chronic Hepatitis B | Phase 2 | 2018-02-28 |
| Active Not Recruiting | Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) Primary Biliary Cirrhosis | Phase 3 | 2017-12-12 |
| Terminated | Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudom Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization, Cystic Fibrosis | Phase 3 | 2017-11-28 |
| Completed | Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impair Hepatic Impairment | Phase 1 | 2017-11-27 |
| Completed | Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Canc Breast Cancer | Phase 3 | 2017-11-07 |
| Completed | Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephro Lupus Membranous Nephropathy | Phase 2 | 2017-10-06 |
| Terminated | Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malign Hematological Malignancies | Phase 1 | 2017-09-08 |
| Terminated | Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis Noninfectious Uveitis | Phase 2 | 2017-07-26 |
| Completed | Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxi Chronic Hepatitis B | Phase 2 | 2017-06-29 |
| Completed | Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Sta Hepatitis C Virus Infection | Phase 2 | 2017-06-27 |
| Completed | Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Im HIV-1-infection | Phase 3 | 2017-06-12 |
| Completed | Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Act Cutaneous Lupus Erythematosus | Phase 2 | 2017-05-24 |
| Terminated | Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults Hematologic Malignancy, Acute Myeloid Leukemia | Phase 1 | 2017-05-19 |
| Completed | Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Viru HIV-1 Infection | Phase 1 | 2017-05-09 |
| Completed | Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren' Sjogren's Syndrome | Phase 2 | 2017-05-01 |
| Completed | Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who P Hepatitis C Virus Infection | Phase 3 | 2017-04-25 |
| Completed | Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD) Small Bowel Crohn's Disease | Phase 2 | 2017-04-11 |
| Completed | Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disea Fistulizing Crohn's Disease | Phase 2 | 2017-04-06 |
| Completed | Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adul Chronic Lymphocytic Leukemia | Phase 2 | 2017-04-06 |
| Completed | Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infe Hepatitis C Virus Infection | Phase 3 | 2017-03-23 |
| Completed | Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Re Chronic Hepatitis C | Phase 2 | 2017-03-22 |
| Terminated | Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibros Nonalcoholic Steatohepatitis | Phase 3 | 2017-02-13 |
| Terminated | Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (N Nonalcoholic Steatohepatitis | Phase 3 | 2017-01-30 |
| Completed | Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chroni Hepatitis C Virus Infection | Phase 2 | 2017-01-26 |
| Completed | Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks i Hepatitis C Virus Infection | Phase 2 | 2017-01-23 |
| Terminated | GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Advanced Estrogen Receptor Positive HER2- Breast Cancer | Phase 1 / Phase 2 | 2017-01-10 |
| Completed | Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Chronic Hepatitis B | Phase 3 | 2016-12-29 |
| Completed | Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection an Hepatitis C Virus Infection | Phase 3 | 2016-12-26 |
| Terminated | Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With M Rheumatoid Arthritis | Phase 2 | 2016-12-15 |
| Completed | Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without O Chronic Lymphocytic Leukemia | Phase 2 | 2016-12-13 |
| Completed | Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea Hepatitis C Virus | — | 2016-12-05 |
| Terminated | Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangit Primary Biliary Cholangitis | Phase 2 | 2016-12-01 |
| Completed | Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholan Primary Sclerosing Cholangitis | Phase 2 | 2016-11-29 |
| Completed | Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) Primary Biliary Cirrhosis | Phase 2 | 2016-11-28 |
| Completed | Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function Inflammatory Disease | Phase 1 | 2016-11-21 |
| Terminated | Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Non Hodgkin Lymphoma | Phase 1 / Phase 2 | 2016-11-21 |
| Completed | Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adult Ulcerative Colitis | Phase 3 | 2016-11-14 |
| Terminated | Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis Cystic Fibrosis | Phase 2 | 2016-11-04 |
| Completed | Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Co Solid Tumor, Colorectal Cancer | Phase 1 / Phase 2 | 2016-11-02 |
| Recruiting | Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infectio Chronic Hepatitis B | Phase 2 | 2016-11-01 |
| Completed | Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice HCV Infection | — | 2016-10-28 |
| Completed | Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitis (NASH) | Phase 2 | 2016-10-26 |
| Completed | Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepati Nonalcoholic Steatohepatitis (NASH) | Phase 1 | 2016-09-23 |
| Active Not Recruiting | Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children Wi HIV-1 Infection | Phase 2 / Phase 3 | 2016-09-21 |
| Completed | Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background T Rheumatoid Arthritis | Phase 2 | 2016-09-21 |
| Terminated | Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Can Gastric Adenocarcinoma | Phase 1 | 2016-09-20 |
| Completed | Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regim Chronic Hepatitis B | Phase 2 | 2016-09-16 |
| Completed | Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infectio Hepatitis C Virus | — | 2016-09-09 |
| Active Not Recruiting | Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combin Pre-Exposure Prophylaxis of HIV-1 Infection | Phase 3 | 2016-09-02 |
| Completed | Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in A Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2016-09-01 |
| Completed | Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic H Alcoholic Hepatitis (AH) | Phase 2 | 2016-09-01 |
| Completed | Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2016-08-30 |
| Completed | Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV Hepatitis C Virus Infection | Phase 2 | 2016-08-28 |
| Completed | Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitis (NASH) | Phase 2 | 2016-08-08 |
| Completed | Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheum Rheumatoid Arthritis | Phase 3 | 2016-08-08 |
| Withdrawn | Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Ca Triple-negative Breast Cancer | Phase 2 | 2016-08-01 |
| Completed | Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Hepatitis C Virus Infection | Phase 2 | 2016-07-29 |
| Completed | Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Hav Hepatitis C Virus Infection | Phase 2 | 2016-07-27 |
| Completed | Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to B Rheumatoid Arthritis | Phase 3 | 2016-07-27 |
| Completed | Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Ge Hepatitis C Virus Infection | Phase 3 | 2016-07-25 |
| Completed | Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC) | Phase 1 | 2016-07-13 |
| Completed | Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Stea Nonalcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | 2016-06-13 |
| Completed | Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation Hepatitis C Virus Infection | Phase 2 | 2016-06-12 |
| Terminated | Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy Chronic Graft Versus Host Disease | Phase 2 | 2016-05-27 |
| Terminated | Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibi Lymphoid Malignancies | Phase 4 | 2016-05-04 |
| Completed | Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic Hepatitis C Virus Infection | Phase 3 | 2016-04-19 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infectio Hepatitis C Virus Infection | Phase 3 | 2016-04-12 |
| Completed | Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Hepatitis C Virus Infection | Phase 3 | 2016-04-04 |
| Completed | Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Partic HIV-1 Infection, HCV Infection | Phase 3 | 2016-04-01 |
| Completed | Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologi HIV-1 Infection | Phase 3 | 2016-02-19 |
| Terminated | Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants Wi Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2016-02-11 |
| Completed | Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants Rheumatoid Arthritis | Phase 1 | 2016-01-26 |
| Completed | Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS- Nonalcoholic Steatohepatitis (NASH) | Phase 1 | 2016-01-20 |
| Terminated | Dose Optimization Study of Idelalisib in Follicular Lymphoma Follicular Lymphoma | Phase 3 | 2016-01-14 |
| Completed | Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection Respiratory Syncytial Virus (RSV) | Phase 2 | 2015-12-31 |
| Terminated | Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia (CLL) | Phase 1 | 2015-12-29 |
| Completed | Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV I Hepatitis C Virus Infection | Phase 3 | 2015-12-23 |
| Completed | Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Ch Hepatitis C Virus Infection | Phase 3 | 2015-12-23 |
| Completed | Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabi HIV-1 Infection | Phase 3 | 2015-12-22 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfec Hepatitis C Virus Infection | Phase 3 | 2015-12-22 |
| Completed | Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed D HIV-1 Infection | Phase 3 | 2015-12-17 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination HIV-1 Infection | Phase 3 | 2015-12-14 |
| Terminated | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In C Metastatic Castrate-Resistant Prostate Cancer | Phase 1 / Phase 2 | 2015-12-08 |
| Completed | Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infe Hepatitis C | — | 2015-11-30 |
| Completed | Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Hepatitis C Virus | — | 2015-11-30 |
| Completed | Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darun HIV-1 Infection | Phase 3 | 2015-11-20 |
| Completed | Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (F HIV-1 Infection | Phase 3 | 2015-11-18 |
| Completed | Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function Oncology | Phase 1 | 2015-11-16 |
| Completed | Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic H Hepatitis C | Phase 3 | 2015-11-16 |
| Completed | Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/D HIV-1 Infection | Phase 3 | 2015-11-13 |
| Completed | Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatiti Hepatitis C | — | 2015-11-12 |
| Terminated | Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Hepatitis C Virus Infection | Phase 3 | 2015-11-11 |
| Completed | Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adu HIV-1 Infection | Phase 3 | 2015-11-11 |
| Completed | Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegrav HIV-1 Infection | Phase 3 | 2015-11-11 |
| Completed | Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previ Hepatitis C | Phase 3 | 2015-11-11 |
| Completed | Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoprox Chronic Hepatitis B | Phase 2 | 2015-11-10 |
| Terminated | Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis Primary Biliary Cirrhosis (PBC) | Phase 2 | 2015-11-04 |
| Completed | CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | 2015-11-01 |
| Completed | Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a HCV Infection | Phase 1 | 2015-10-29 |
| Terminated | A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Ant Hepatitis C Virus Infection | — | 2015-10-21 |
| Completed | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocar Gastric Adenocarcinoma | Phase 3 | 2015-10-13 |
| Completed | Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatiti Hepatitis C Virus Infection | — | 2015-09-15 |
| Terminated | Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Ly Follicular Lymphoma, Small Lymphocytic Lymphoma | Phase 2 | 2015-09-14 |
| Completed | Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Ma Relapsed/Refractory B-cell Malignancies | Phase 1 | 2015-09-10 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Ad Hepatitis C Virus Infection | Phase 3 | 2015-09-07 |
| Terminated | Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis | Phase 2 / Phase 3 | 2015-09-01 |
| Completed | Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Functio Diabetic Kidney Disease | Phase 1 | 2015-08-18 |
| Completed | Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult S PD Effects of GS-0976 (NDI-010976) on Fractional DNL | Phase 1 | 2015-08-01 |
| Terminated | Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metast Previously Untreated Pancreatic Ductal Adenocarcinoma, Relapsed/Refractory Pancreatic Ductal Adenocarcinoma | Phase 1 | 2015-07-30 |
| Completed | Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Hepatitis C Virus Infection | Phase 2 | 2015-07-29 |
| Completed | Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndr LQT2 Syndrome | Phase 1 | 2015-07-20 |
| Terminated | Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection Hepatitis B | Phase 4 | 2015-07-03 |
| Completed | Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepat Hepatitis C Virus Infection | Phase 3 | 2015-07-01 |
| Terminated | Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2015-07-01 |
| Completed | Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containin HIV-1 Infection | Phase 3 | 2015-06-29 |
| Completed | Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hep HBV, Chronic HBV Infection | Phase 3 | 2015-06-19 |
| Completed | Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hep HBV, Chronic HBV Infection | Phase 3 | 2015-06-19 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection Hepatitis C Virus Infection | Phase 3 | 2015-06-17 |
| Terminated | Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therap B-cell Malignancies | Phase 1 | 2015-06-16 |
| Completed | Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Non Non-Alcoholic Steatohepatitis (NASH) | Phase 2 | 2015-06-08 |
| Terminated | Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Myelofibrosis | Phase 1 | 2015-06-05 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Hepatitis C Infection With HIV Co-Infection | Phase 2 | 2015-06-01 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chr Hepatitis C Virus Infection | Phase 2 | 2015-05-22 |
| Terminated | Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2015-05-06 |
| Completed | Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment HCV Infection | Phase 1 | 2015-05-05 |
| Withdrawn | GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease Ischemic Heart Disease | Phase 2 | 2015-05-01 |
| Completed | Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function Long QT Syndrome | Phase 1 | 2015-05-01 |
| Terminated | Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease Crohn's Disease | Phase 2 | 2015-04-30 |
| Terminated | Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination Wit Chronic Lymphocytic Leukemia | Phase 3 | 2015-04-21 |
| Completed | Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function HIV | Phase 1 | 2015-04-17 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Wee Hepatitis C Virus Infection | Phase 2 | 2015-04-01 |
| Completed | Study to Evaluate the Effects of MBX-8025 in Patients With HoFH Homozygous Familial Hypercholesterolemia | Phase 2 | 2015-04-01 |
| Completed | Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairm HCV Infection | Phase 1 | 2015-03-24 |
| Completed | Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/T HIV-1 Infection | Phase 2 | 2015-03-23 |
| Completed | Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function Long QT Syndrome | Phase 1 | 2015-03-19 |
| Completed | Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) Solid Tumors and Lymphomas | Phase 1 | 2015-03-16 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Si Hepatitis C Virus Infection | Phase 2 | 2015-03-02 |
| Completed | Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection Hepatitis C Virus Infection | Phase 3 | 2015-02-23 |
| Completed | Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Hepatitis C Virus Infection | Phase 2 | 2015-02-17 |
| Completed | Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Hepatitis C Virus Infection | Phase 2 | 2015-02-16 |
| Terminated | Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy Hypertrophic Cardiomyopathy | Phase 2 / Phase 3 | 2015-02-05 |
| Completed | Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults Long QT Syndrome | Phase 1 | 2015-02-01 |
| Completed | Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Respiratory Syncytial Virus Infection | Phase 2 | 2015-01-31 |
| Completed | Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults HIV-1 Infection | Phase 1 | 2015-01-29 |
| Completed | Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate HIV-1 Infection | Phase 3 | 2015-01-26 |
| Completed | Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/T HIV-1 Infection | Phase 3 | 2015-01-26 |
| Completed | Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Syncytial Virus | Phase 2 | 2015-01-23 |
| Completed | Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infect HIV-1 | Phase 2 / Phase 3 | 2015-01-20 |
| Terminated | Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Foll Follicular Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | 2015-01-01 |
| Terminated | A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With Hepatitis C Virus Infection | — | 2014-12-29 |
| Completed | Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function a Hepatitis B Virus | Phase 1 | 2014-12-22 |
| Terminated | Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrom Long QT Syndrome Type 3 | Phase 3 | 2014-12-17 |
| Completed | Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Pl HIV-1 Infection | Phase 4 | 2014-12-15 |
| Terminated | Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic He Chronic Hepatitis B | — | 2014-12-09 |
| Completed | Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescen HIV | Phase 2 / Phase 3 | 2014-12-03 |
| Completed | Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Ad Hepatitis C Virus Infection | Phase 2 | 2014-12-01 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children Hepatitis C Virus Infection | Phase 2 | 2014-11-05 |
| Completed | Selonsertib in Adults With Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension | Phase 2 | 2014-11-01 |
| Completed | Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodef HIV-1 Infection | Phase 1 | 2014-10-24 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidn Hepatitis C Virus Infection | Phase 2 | 2014-10-14 |
| Completed | Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Chola Primary Sclerosing Cholangitis | — | 2014-10-01 |
| Completed | Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relap Chronic Lymphocytic Leukemia, Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma | Phase 1 | 2014-10-01 |
| Completed | Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Hepatitis C Virus Infection | Phase 3 | 2014-09-01 |
| Completed | Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchro Ventricular Arrhythmia | Phase 2 | 2014-09-01 |
| Terminated | Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion | Phase 2 | 2014-08-06 |
| Completed | Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection Chronic Hepatitis C | Phase 2 | 2014-08-04 |
| Completed | Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients W Gout, Hyperuricemia | Phase 2 | 2014-08-01 |
| Completed | Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2014-08-01 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Hepatitis C Virus Infection | Phase 2 | 2014-08-01 |
| Completed | Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody Solid Tumor | Phase 1 | 2014-08-01 |
| Completed | Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults Ulcerative Colitis | Phase 1 | 2014-08-01 |
| Completed | Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Pa Chronic Hepatitis B | Phase 2 | 2014-07-24 |
| Completed | Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Inf Hepatitis C Virus Infection | Phase 2 | 2014-07-07 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Parti HCV Infection | Phase 2 | 2014-07-01 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experience Hepatitis C Virus Infection | Phase 2 | 2014-07-01 |
| Completed | Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection Hepatitis C Virus Infection | Phase 3 | 2014-07-01 |
| Completed | Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirr Hepatitis C Virus Infection | Phase 3 | 2014-07-01 |
| Completed | Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Hepatitis C Virus Infection | Phase 3 | 2014-07-01 |
| Completed | Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally Chronic Hepatitis B | Phase 2 | 2014-06-30 |
| Completed | Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults Wit Hepatitis C Virus Infection | Phase 1 | 2014-06-13 |
| Completed | Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus ( Respiratory Syncytial Virus Infection | Phase 2 | 2014-06-09 |
| Completed | Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease Diabetic Kidney Disease | Phase 2 | 2014-06-01 |
| Completed | Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis Hepatitis C Virus Infection | Phase 4 | 2014-06-01 |
| Completed | Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Con HIV-1 Infection | Phase 3 | 2014-05-06 |
| Completed | Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects Wi Chronic HCV Infection | Phase 2 | 2014-04-01 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disea Chronic Obstructive Pulmonary Disease | Phase 1 | 2014-03-11 |
| Completed | Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV In Chronic HCV Infection | Phase 3 | 2014-03-01 |
| Completed | Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Pa Gout | Phase 2 | 2014-03-01 |
| Completed | Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienc Chronic Genotype 4 HCV, Chronic Genotype 5 HCV | Phase 2 | 2014-03-01 |
| Completed | Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults HIV, HBV | Phase 3 | 2014-02-25 |
| Terminated | Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Unt Chronic Lymphocytic Leukemia | Phase 3 | 2014-02-05 |
| Completed | Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Geno Hepatitis C Virus, HIV | Phase 3 | 2014-02-01 |
| Active Not Recruiting | Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenof Acquired Immune Deficiency Syndrome (AIDS), HIV Infections | Phase 2 / Phase 3 | 2014-01-16 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liv Chronic HCV Infection | Phase 2 | 2014-01-01 |
| Completed | Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Re Hepatitis C Virus | Phase 1 | 2013-12-16 |
| Completed | Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HC Chronic HCV Infection | Phase 3 | 2013-12-10 |
| Completed | Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection Chronic HCV Infection | Phase 3 | 2013-12-10 |
| Terminated | Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic C Metastatic Pancreatic Cancer, Pancreatic Cancer | Phase 3 | 2013-12-01 |
| Terminated | Phase I Study of Milatuzumab for Graft Versus Host Disease GVHD (Acute or Chronic), Acute Myeloid or Lymphoblastic Leukemia (AML or ALL), Myelodysplastic Syndrome | Phase 1 | 2013-12-01 |
| Completed | Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elviteg HIV, HIV Infections, Acquired Immunodeficiency Syndrome | Phase 3 | 2013-10-25 |
| Completed | Adherence, HIV-1 Infection, Resistance, and Renal and Skeletal Adverse Event in Individuals Taking Truvada® fo HIV | — | 2013-10-07 |
| Completed | Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency HCV Infection | Phase 2 | 2013-10-07 |
| Completed | Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Chronic HCV Infection | Phase 3 | 2013-10-01 |
| Completed | Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chr HCV Infection | Phase 2 | 2013-10-01 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Chronic HCV Infection | Phase 2 | 2013-10-01 |
| Completed | SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic Hepatitis C | Phase 3 | 2013-09-24 |
| Completed | Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B Chronic HBV Infection | Phase 2 | 2013-09-13 |
| Completed | Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With C HBeAg-negative Chronic Hepatitis B | Phase 3 | 2013-09-12 |
| Completed | Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With C HBeAg-positive Chronic Hepatitis B | Phase 3 | 2013-09-11 |
| Completed | Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Daruna HIV-1, HIV Infections, Acquired Immunodeficiency Syndrome | Phase 3 | 2013-09-03 |
| Completed | A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Proph HIV | — | 2013-09-02 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Dise Chronic HCV Infection | Phase 2 | 2013-09-01 |
| Withdrawn | A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2013-09-01 |
| Terminated | Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With Acquired Immune Deficiency Syndrome (AIDS), HIV Infections | Phase 2 / Phase 3 | 2013-08-26 |
| Completed | Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV Infection Hepatitis C | Phase 2 | 2013-07-01 |
| Terminated | Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma | Phase 2 | 2013-06-20 |
| Completed | Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects Hepatitis C | Phase 2 | 2013-06-01 |
| Completed | Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic Hepatitis C | Phase 3 | 2013-06-01 |
| Completed | Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricit Acquired Immune Deficiency Syndrome (AIDS), HIV Infections | Phase 2 / Phase 3 | 2013-05-06 |
| Withdrawn | Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV) Respiratory Syncytial Virus Infections | Phase 1 | 2013-05-01 |
| Completed | Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF Cystic Fibrosis | Phase 1 | 2013-05-01 |
| Completed | A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects Ischemic Heart Disease | Phase 1 | 2013-05-01 |
| Completed | Study of the Effect of GS-6615 in Subjects With LQT-3 Long QT Syndrome | Phase 1 | 2013-05-01 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION- Chronic Hepatitis C Virus | Phase 3 | 2013-05-01 |
| Completed | A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Chronic Lymphocytic Leukemia | Phase 1 | 2013-05-01 |
| Completed | A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis i Pre-exposure Prophylaxis for Prevention of HIV Infection | — | 2013-04-22 |
| Completed | A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Sc Limited Scleroderma, Diffuse Scleroderma | — | 2013-04-01 |
| Completed | A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes. Type 2 Diabetes Mellitus | Phase 1 | 2013-04-01 |
| Completed | Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participan Chronic Hepatitis C | Phase 2 | 2013-04-01 |
| Completed | Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chron Hepatitis C | Phase 2 | 2013-04-01 |
| Completed | Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemothe Pancreatic Cancer, Non-small Cell Lung Cancer, Esophagogastric Cancer | Phase 1 | 2013-03-29 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults Ulcerative Colitis | Phase 1 | 2013-03-28 |
| Completed | Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combinati HIV, HIV Infections | Phase 3 | 2013-03-27 |
| Completed | Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairm HIV, HIV Infections | Phase 3 | 2013-03-27 |
| Terminated | Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapse Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma | Phase 2 | 2013-03-14 |
| Completed | Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Trea HIV, HIV Infections | Phase 3 | 2013-03-12 |
| Completed | Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Chol Primary Sclerosing Cholangitis (PSC) | Phase 2 | 2013-03-04 |
| Completed | A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806 RSV Infection | Phase 1 | 2013-03-01 |
| Completed | A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moder Chronic Hepatitis C | Phase 1 | 2013-03-01 |
| Completed | Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Hepatitis C Virus | Phase 3 | 2013-03-01 |
| Terminated | Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL Non-hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma | Phase 1 | 2013-03-01 |
| Terminated | Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer | Phase 1 / Phase 2 | 2013-02-12 |
| Completed | Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection Hepatitis C | Phase 3 | 2013-02-01 |
| Completed | Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Hepatitis C | Phase 2 | 2013-02-01 |
| Completed | A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects HIV Infections | — | 2013-02-01 |
| Terminated | Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis ( Idiopathic Pulmonary Fibrosis | Phase 2 | 2013-01-31 |
| Terminated | Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non- Indolent Non-Hodgkin's Lymphomas | Phase 3 | 2013-01-16 |
| Terminated | Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Trea Indolent Non-Hodgkin's Lymphomas | Phase 3 | 2013-01-02 |
| Completed | A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication HIV Infection | — | 2013-01-01 |
| Completed | A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Healthy Volunteers | Phase 1 | 2013-01-01 |
| Completed | A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Gen Chronic Hepatitis C, Human Immunodeficiency Virus | Phase 3 | 2013-01-01 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subje Chronic Hepatitis C Virus | Phase 3 | 2013-01-01 |
| Completed | Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positi HIV, HIV Infections | Phase 3 | 2012-12-26 |
| Completed | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2012-12-17 |
| Completed | Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Acquired Immunodeficiency Syndrome, HIV Infections | Phase 2 / Phase 3 | 2012-12-06 |
| Active Not Recruiting | Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Plac Chronic Hepatitis B | Phase 3 | 2012-12-06 |
| Terminated | Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Seco Liver Fibrosis Due to NASH | Phase 2 | 2012-12-05 |
| Terminated | Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Le Chronic Lymphocytic Leukemia | Phase 3 | 2012-12-04 |
| Completed | Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Cystic Fibrosis | Phase 3 | 2012-12-01 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Partici Chronic Hepatitis C Virus | Phase 1 | 2012-11-06 |
| Completed | Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age Respiratory Syncytial Virus Infections | — | 2012-11-01 |
| Completed | Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Recurrent Chronic Hepatitis C Virus, Post Liver Transplant | Phase 2 | 2012-11-01 |
| Completed | A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies Lymphoid Malignancies | Phase 1 | 2012-11-01 |
| Completed | Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) Respiratory Syncytial Virus Infections | Phase 2 | 2012-11-01 |
| Terminated | Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH Liver Fibrosis Due to NASH | Phase 2 | 2012-10-29 |
| Completed | Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatme Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | 2012-10-24 |
| Terminated | Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis | Phase 2 | 2012-10-18 |
| Completed | Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis Liver Fibrosis, Hepatitis C, HIV | Phase 2 | 2012-10-04 |
| Terminated | Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-U Chronic Lymphocytic Leukemia | Phase 3 | 2012-10-03 |
| Completed | Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus | Phase 2 | 2012-10-01 |
| Terminated | A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Su Cystic Fibrosis, Chronic Obstructive Pulmonary Disease | Phase 1 | 2012-10-01 |
| Completed | Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects Chronic Hepatitis C Virus | Phase 2 | 2012-10-01 |
| Completed | Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HC Hepatitis C | Phase 3 | 2012-09-01 |
| Completed | Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the T Chronic Hepatitis C Virus | Phase 3 | 2012-09-01 |
| Completed | Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participan Non Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia | Phase 1 | 2012-08-17 |
| Terminated | Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2012-08-01 |
| Withdrawn | A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) a Chronic Lymphocytic Leukemia | Phase 2 | 2012-08-01 |
| Terminated | A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tol Severe Renal Impairment | Phase 1 | 2012-07-01 |
| Completed | Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Hu Hepatitis C, Human Immunodeficiency Virus | Phase 3 | 2012-07-01 |
| Completed | Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without L Hepatitis C, Cirrhosis, Portal Hypertension | Phase 2 | 2012-07-01 |
| Completed | Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Prev Chronic Lymphocytic Leukemia | Phase 3 | 2012-06-15 |
| Completed | A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Al Type 2 Diabetes Mellitus | Phase 3 | 2012-06-01 |
| Completed | Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV I Chronic Hepatitis C | Phase 3 | 2012-06-01 |
| Completed | Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Geno Chronic Hepatitis C | Phase 3 | 2012-06-01 |
| Completed | Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV In Chronic Hepatitis C | Phase 3 | 2012-06-01 |
| Completed | Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients Hepatitis B, Hepatitis C | — | 2012-05-01 |
| Completed | Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy Hepatitis B | — | 2012-04-26 |
| Completed | Gilead Sustained Virologic Response (SVR) Registry Hepatitis C, Chronic | — | 2012-04-13 |
| Completed | A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection Hepatitis B | Phase 1 | 2012-04-01 |
| Completed | A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B Hepatitis B, HBV | Phase 1 | 2012-04-01 |
| Completed | D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults Acquired Immunodeficiency Syndrome, HIV Infections | Phase 2 | 2012-04-01 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previousl Chronic Lymphocytic Leukemia | Phase 3 | 2012-04-01 |
| Completed | Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Int Chronic Hepatitis C | Phase 3 | 2012-03-01 |
| Completed | Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurr Hepatitis C, Hepatocellular Carcinoma | Phase 2 | 2012-03-01 |
| Completed | A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B Chronic Hepatitis B | Phase 1 | 2012-03-01 |
| Withdrawn | A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Th Metastatic Pancreatic Adenocarcinoma, Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 1 | 2012-03-01 |
| Completed | A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C Hepatitis C | Phase 1 | 2012-03-01 |
| Completed | Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatiti Hepatitis C, HIV | Phase 1 / Phase 2 | 2012-03-01 |
| Completed | Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine Type 2 Diabetes Mellitus | Phase 1 | 2012-02-01 |
| Completed | Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine Type 2 Diabetes Mellitus | Phase 1 | 2012-02-01 |
| Completed | Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients Wit Atrial Fibrillation | Phase 2 | 2012-01-24 |
| Completed | Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenof Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | 2012-01-01 |
| Completed | Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2012-01-01 |
| Completed | Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Tre Acquired Immunodeficiency Syndrome, HIV Infections | Phase 2 | 2011-12-28 |
| Completed | A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response Hepatitis C, Chronic | — | 2011-12-19 |
| Completed | Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways Cystic Fibrosis, Pseudomonas Aeruginosa | Phase 3 | 2011-12-01 |
| Terminated | Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma Colorectal Cancer | Phase 2 | 2011-12-01 |
| Completed | Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus E Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | 2011-12-01 |
| Completed | Phase 3 Study of Sofosbuvir and Ribavirin Hepatitis C | Phase 3 | 2011-12-01 |
| Completed | Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2011-11-01 |
| Completed | Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis Liver Fibrosis | Phase 2 | 2011-11-01 |
| Completed | Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitab Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | 2011-11-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Pancreatic Cancer | Phase 2 | 2011-11-01 |
| Completed | Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) Coronary Artery Disease, Angina Pectoris | Phase 3 | 2011-10-01 |
| Completed | GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hep Hepatitis C, Chronic | Phase 2 | 2011-09-01 |
| Completed | Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina Angina Pectoris, Coronary Artery Disease, Type 2 Diabetes Mellitus | Phase 4 | 2011-09-01 |
| Completed | Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma Hodgkin Lymphoma | Phase 2 | 2011-09-01 |
| Completed | GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic G Chronic Genotype 1a or 1b HCV Infection | Phase 2 | 2011-09-01 |
| Completed | Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Hepatitis C | Phase 1 | 2011-09-01 |
| Completed | Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection Hepatitis C, Chronic | Phase 2 | 2011-09-01 |
| Completed | Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | 2011-09-01 |
| Completed | Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Pati Hyperuricemia, Gout | Phase 2 | 2011-08-01 |
| Terminated | GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genot Chronic Hepatitis C | Phase 2 | 2011-08-01 |
| Completed | Aztreonam Lysine for Pseudomonas Infection Eradication Study Cystic Fibrosis | Phase 2 | 2011-08-01 |
| Completed | Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Pa Cystic Fibrosis | — | 2011-08-01 |
| Completed | Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Exp Hepatitis C, Chronic | Phase 2 | 2011-07-01 |
| Completed | GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Gen Hepatitis C, Chronic | Phase 2 | 2011-07-01 |
| Completed | Open-Label Hepatic Impairment Study Hepatitis C | Phase 1 | 2011-07-01 |
| Completed | Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocyth Myelofibrosis | Phase 2 | 2011-06-30 |
| Completed | Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients Gout | Phase 2 | 2011-06-01 |
| Completed | GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis Hepatitis C, Chronic | Phase 2 | 2011-05-01 |
| Completed | Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout Hyperuricemia, Gout | Phase 2 | 2011-05-01 |
| Completed | Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate R Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | 2011-05-01 |
| Withdrawn | A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Angina Pectoris, Coronary Artery Disease, Type 2 Diabetes Mellitus | Phase 4 | 2011-05-01 |
| Completed | Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer Metastatic Colorectal Cancer | Phase 1 | 2011-05-01 |
| Completed | Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB Chronic Hepatitis B | Phase 4 | 2011-04-26 |
| Completed | Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis Bronchiectasis | Phase 3 | 2011-04-01 |
| Completed | Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leu Invasive Fungal Disease | Phase 3 | 2011-04-01 |
| Completed | Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis Bronchiectasis | Phase 3 | 2011-04-01 |
| Completed | Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-I Chronic Hepatitis B | Phase 4 | 2011-04-01 |
| Completed | Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma | Phase 2 | 2011-03-18 |
| Completed | Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6 Hepatitis C, Chronic | Phase 2 | 2011-03-01 |
| Withdrawn | Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 1 | 2011-02-01 |
| Completed | Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymph Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma | Phase 1 / Phase 2 | 2011-02-01 |
| Completed | Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Di HIV-1 Infection | Phase 3 | 2011-02-01 |
| Completed | Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fuma HIV-1 Infection | Phase 2 | 2011-01-01 |
| Completed | A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment N Hepatitis C, Chronic | Phase 1 | 2011-01-01 |
| Completed | Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT Chronic Hepatitis C Infection | Phase 2 | 2010-12-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Idiopathic Pulmonary Fibrosis | Phase 1 | 2010-12-01 |
| Completed | Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nu HIV-1 Infection | Phase 3 | 2010-11-01 |
| Terminated | A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | Phase 2 | 2010-10-01 |
| Completed | A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Pre Chronic Hepatitis C Infection | Phase 2 | 2010-10-01 |
| Completed | A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Withou Hepatitis C, Chronic | Phase 2 | 2010-10-01 |
| Completed | Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging Myocardial Perfusion Imaging, Myocardial Ischemia | Phase 4 | 2010-09-01 |
| Completed | A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis HCV Infection | Phase 1 | 2010-08-01 |
| Completed | Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Hepatitis C Virus | Phase 2 | 2010-08-01 |
| Completed | Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan Hepatitis B | Phase 2 | 2010-08-01 |
| Terminated | A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2010-07-01 |